This study aimed to evaluate the efficacy of percutaneous coronary intervention (PCI) for significant atherosclerosis lesions proximal to myocardial bridge (MB) at left anterior descending coronary artery (LAD).
T raditionally, the segment of major epicardial coronary artery, which runs through the myocardium, is called intramural coronary artery. Accordingly, the muscle fiber over the intramural coronary artery is called myocardial bridge (MB). MB is, in general, located at the mid left anterior descending artery (LAD), where the main angiographic findings reveal images of systolic compression with the involved coronary artery.
1) It was once considered as benign anatomical variation; however, recently several studies have confirmed that it has a close relationship with severe complications such as acute myocardial infarction, coronary spasm, malignant arrhythmias, syncope, and sudden death due to cardiac failure.
2) Its therapeutic implications have always remained the focus of several studies. [3] [4] [5] Stent implantation into MB, due to the high rate of stent restenosis, 6, 7) coronary artery perforation, stent fracture, and other problems, has been questioned. [8] [9] [10] Vessels proximal to MB, since the long-term hemodynamic changes and the resulting shear stress, are often associated with significant atherosclerostic stenosis. 11, 12) Both anatomical findings and intravenous ultrasound (IVUS) studies indicated that the incidence of MB is as high as 86%. 13) For severe atherosclerotic stenosis proximal to MB, the efficacy and safety of stent implantation in the short-and long-term follow-up remain unclear.
Therefore, we designed this study to evaluate the efficacy and safety of stent implantation for significant atherosclerosis lesions in the segments proximal to MB at LAD.
Methods
Patient enrollment: A total of 330 consecutive patients with acute coronary syndrome (ACS) were admitted to the department of cardiology, affiliated Hospital of Hebei University for LAD intervention, and were included into our study from July 2013 to July 2015. The cardiac enzymes, liver and kidney function, blood lipids, blood glucose, and echocardiography were routinely measured within 24 h after admission. All these patients received immediate percutaneous coronary intervention (PCI) or elective PCI, based on the physician's discretion. Patients with significant single LAD atherosclerotic stenosis of over 70%, and without significant stenosis of other coronary branches, were enrolled. For patients with 50%-70% stenosis, the interventional strategy was based on the physician's discretion. Patients with left main arterial stenosis, double vessels, or multivessel lesions, as well as patients with cardiogenic shock, severe liver or renal dysfunction, and contraindications of clopidogrel or aspirin, were excluded from this study. The diagnostic criteria of MB includes typical transient systolic compression of the coronary vessel with partial or complete decompression during diastole (milking effect) 14) at least in one angiographic projection. Proximal atherosclerotic lesions of MB are defined as the significant narrowing, which is located more than 5 mm away from MB. Significant LAD atherosclerotic lesions with distal MB were found in 48 patients, whereas significant LAD lesions without distal MB were found in 282 cases. Mean age of the selected patients was 56.8 ± 9.6 (46-66) years with 209 males and 121 females. This study was approved by the ethical committee of affiliated hospital of Hebei University. Meanwhile, all patients signed the informed consent. Intervention and medications: All patients received coronary angiography, and the images of multiprojection (left coronary 4-5 positions, right coronary artery 2-3 positions) were recorded. The MB was identified by at least two experienced interventionists simultaneously. Stent was implanted according to the known standard method. The interfacing diagonal artery of over 2.0 mm in diameter was protected with guiding wires. Although a single stent was preferred, double stent strategy was also used in certain cases based on the operator's decision (e.g., Tstenting and small protrusion technique [TAP], step Crush, Culotte). Drug-eluting stents (DES) (e.g., Firebird2, Excel, Resolute, or Partner stents) were routinely used in these patients. Successful PCI was defined as thrombolysis in myocardial infarction (TIMI) blood flow grade three and residual stenosis lower than 20% without any interventional complications. The loading dose of aspirin and clopidogrel (300 mg, respectively) or ticagrelor (180 mg) was administered before the operation. Heparin (10,000 units) was also used intravenously during the procedure. Platelet glycoprotein IIb/IIIa receptor antagonist (tirofiban) was used in part in the patients during or after the procedure based on the severity of coronary artery lesion. Long-term treatment of aspirin 100 mg qd, clopidogrel 75 mg qd (for at least 12 months), atorvastatin, angiotension converting enzyme inhibitors (ACEI)/angiotensin II recept or blockers (ARB), β-receptor blockers, control of blood pressure 15, 16) and blood glucose, smoking cessation, and physical exercises were routinely described to all of the patients. Clinical follow-up and the study end-point events: All patients were followed up by telephonic or outpatient clinic interview for the major adverse cardiac events (MACE)during their hospital stay, 30 days and 12 months after PCI. Patients accepted repeated coronary angiography in 6-12 months for finding varieties to the stent, such as intimal hyperplasia, restenosis, and thrombus formation. Decreasing of vessel diameter over 50% within stent segment or within 0.5 cm of both distal and proximal to the stent edge was defined as stent restenosis, whereas less than 50% was defined as intimal hyperplasia. Angiographic appearance of a rounded filling defect in the stent was considered as in-stent thrombosis. The MACEs include unstable angina pectoris, acute myocardial infarction, acute heart failure, malignant cardiac arrhythmias, and target vessel revascularization (TVR). TVR was defined as revascularization to more than 70% of the stent restenosis lesions in the related coronary artery using stent or drug eluting balloon. For restenosis of 50-70%, the clinical evidence of ischemia was needed. Statistics: SPSS 20.0 software was used for data analyzing; continuous variables were expressed as mean ± standard deviation. The two independent samples t-test was used for normally distributed data. Count variables were expressed by number and percentage, which were performed through the chi-square test. P < 0.05 was considered as statistically significant. Univariate regression analysis was used to find the statistically significant factors before multivariate Cox proportional hazards regression analysis, which evaluated the risk factors of MACEs and calculated the hazard ratio (HR) as well as 95% confidence intervals (95% CI).
Result Patients basic features:
A total of 330 patients with LAD atherosclerosis lesions were enrolled from July 2013 to July 2015, of which 48 patients had atherosclerosis lesions with distal MB (MB group, n = 48), whereas 282 patients had atherosclerotic stenosis without distal MB (NMB group, n = 282). The percentage of male and smokers in the MB group were higher than that of the NMB group (85.4% versus 66.0%, P = 0.007; 66.7% versus 51.1%, P = 0.045, respectively). There was no difference in the ratio of dyslipidemia patients between the two groups; however, the total cholesterol (5.0 ± 1.3 versus 4.3 ± 0.9, P < 0.05), triglycerides (2.9 ± 3.9 versus 1.8 ± 0.9, P < 0.05), low-density lipoprotein cholesterol (LDL-C) (3.0 ± 1.2 versus 2.6 ± 0.7, P < 0.05), and highdensity lipoprotein cholesterol (HDL-C) (0.9 ± 0.2 versus 1.0 ± 0.2, P < 0.05) in the MB group were significantly abnormal compared to the NMB group. Echocardiography revealed no difference in the left ventricular end-diastolic volume (LVEDV) between the two groups; however, the left ventricular ejection fraction (LVEF) was significantly lower in the MB group than the NMB group (62.5 ± 7.4 versus 65.6 ± 8.2, P = 0.014). Other aspects like the percentage of hypertension, diabetic mellitus, renal and liver THE OUTCOME OF PCI WITH MB AT LAD functions, body mass index, cardiac enzyme, and age revealed no obvious difference between the two groups (Table I).
Coronary angiography findings:
The percentage of patients who received interventional therapy previously was higher in the MB group than the NMB group (18.8% versus 4.3%, P < 0.05). Quantitative angiographic analysis discovered that the average length of proximal stenostic lesions (29.2 ± 10.4 versus 30.1 ± 14.3, P = 0.549) and the degree of stenosis (86.5 ± 6.7% versus 87.9 ± 7.4%, P = 0.181) were not significantly different. In the MB group, the ratio of the stenostic lesions located at the adjacent diagonal branch was significantly higher than that of the NMB group (35.4% versus 19.1%, P = 0.011). The average systolic oppression of MB was 57.5 ± 15.3% and the average distance from athrosclerostic stenosis to the distal MB was 15.2 ± 7.8 mm (Table II) .
Interventional therapy: For both groups, the percutaneous coronary interventional therapy was successfully performed and coronary angiography revealed that TIMI blood flow of LAD achieved grade three without the obvious residual stenosis after PCI. The use of single stent or double stent strategy was similar in the two groups. The types of stent, quantity of LAD stent implant !2, stent diameter and length, postoperative residual stenosis, stent inflation pressure, use of postdilation, and contrast volume did not differ in the two groups. The extent of diagonal branch ostium stenosis was not affected during or after the operation (Table III) . Clinical and angiographic follow-up: All patients were followed up through telephonic or interview at outpatient department and the follow-up period was during the hospital stay, at 30 days and 12 months after PCI. In the MB group, no acute myocardial infarction and malignant ar-Hao, ET AL MB indicates myocardial bridge; NMB, non-myocardial bridge; MACEs, major adverse cardiac events; AP, angina pectoris; AMI, acute myocardial infarction; AHF, acute heart failure; and SCD, sudden cardiac death rhythmias were found during the hospital stay. Nevertheless, one case in this group developed acute intrastent thrombosis in 4 h after PCI with severe chest pain and significant electrocardiogram (ECG) changes, which was later diagnosed as cerebral apoplexy with brain magnetic resonance imaging (MRI); one case developed acute heart failure; and two cases had angina pectoris attack. There was one case of sudden cardiac death without definite causes and five cases of angina pectoris attack in the matched group. These incidences among the two groups were similar (Table IV) . In the 30 days follow-up, 6 patients had recurrent angina pectoris in the MB group, whereas 11 patients had recurrent angina pectoris in the NMB group with an incidence of 12.5% versus 3.9%, respectively (P = 0.032). No significant intergroup differences were found for acute myocardial infarction, acute heart failure, malignant arrhythmias, and sudden cardiac death. The rate of target lesion revascularization and total MACEs in the MB group were significantly higher than the compared group (8.3% versus 0.7%, P = 0.005; 18.2% versus 6.4%, P = 0.008; Table V) .
The 12 months follow-up showed similarities with the results of 30 days follow-up. There were 16 cases of recurrent angina in the MB group, whereas 35 cases in the NMB group (33.3% versus 12.4%, P < 0.001). The rate of acute myocardial infarction, acute heart failure, malignant arrhythmias, and sudden cardiac death were not different between the two groups as before. The rate of the target lesion revascularization and total MACEs were still higher in the MB group than the matched group (14.6% versus 4.3%, P = 0.012; 43.8% versus 17.0%, P < 0.001; Table VI) . Most patients received angiographic reinvestigation in 6-12 months after the operation where 7.8% patients in the NMB group declined such recheck for several reasons. By using IVUS or optical coherence tomography (OCT), 17) we found that the proportion of stent restenosis was higher in the MB group than the NMB group with four and five cases, respectively (8.3% versus 1.8%, P = 0.036). No significant intergroup differences were found for intrastent intimal hyperplasia and intrastent thrombosis (P = 0.175; P = 0.145, respectively). No stent fracture occured in both groups (Table VII) . Multivariate regression: Univariate analysis evaluated dyslipidemia, LVEF, LVEDV, MB, and age, which were THE OUTCOME OF PCI WITH MB AT LAD statistically significant (P < 0.05, respectively) in affecting the occurrence of MACEs among gender, smoking, hypertension, diabetes, dyslipidemia, stent diameter, total stent length and other covariates. These five factors were included into the Cox proportional hazard model. The results revealed that although dyslipidemia (HR = 4.717, 95% CI 2.350-9.468, P < 0.001), age (HR = 1.026, 95% CI 1.002-1.051, P = 0.030), and LVEF (HR = 0.909, 95% CI 0.887-0.932, P < 0.001) were among the strongest independent prognostic factors of MACEs, the existence of MB was also an independent prognostic factor of MACEs (HR = 1.781, 95% CI 1.108-2.863, P = 0.017; Table  VIII) .
Discussion
The main finding of this study proved that MB increased the incidence of stent restenosis to proximal atherosclerostic lesions after PCI. For patients having MB of LAD with proximal significant stenosis, interventional therapy had a higher incidence of MACEs, according to our short-and long-term follow-ups. Furthermore, the existence of MB was significantly associated with MACEs.
Lee, et al. 18) reported that among 551 patients with significant proximal LAD lesion undergoing stent implantation (including 94 cases with MB and 457 cases without MB), the incidence of MACEs was obviously higher in patients complicated with MB than the matched patients, especially the rate of target lesion revascularization after a mean follow-up of 821.26 ± 400.38 days. Multiple regression analysis revealed that MB was the strongest independent risk factor of MACEs. Su, et al. 19) found that sirolimus-eluting stent implantation for such patients with MB would result in more restenosis (30.4%) and more MACEs (65.2%). Hence, the efficacy of PCI for long-term seemed unsatisfactory; however, these studies did not exclude cases with significant left main stenosis or multives-sel lesions, which affected the incidence of MACEs. Alternatively, these studies did not clearly describe the specific location of MB. For single significant atherosclerostic stenosis of LAD with its myocardial bridging, the effects of PCI to the proximal lesion and the impacts of MB on MACEs during short-and long-term were not reported so far.
In this study, we strictly selected patients only with LAD atherosclerotic stenosis ! 70% and compared the short-and long-term effects of stent implantation between patients with distal MB and those without distal MB. This point differs from other similar studies.
Stent restenosis affected the prognosis of patients undergoing PCI. Early studies reported that the rate of restenosis using DES was 7.6%-17.2%. 20, 21) Nevertheless, in our study, the rate of stent restenosis for non-MB coronary artery dropped to 1.8%. This may be related to the improvements in design of the drug-eluting stents, stent implanted technique, as well as the prevalence of predilation and postdilation to facilitate better expansion and adherence of stents during the procedure. Alternatively, we found that among patients with MB, the rate of stent restenosis (8.3%) was considerably higher than those without MB (1.8%). We considered that tremendous hemodynamical changes proximal to MB may play a primary role in disturbing the endothelial function and injuries of vascellum that cause restenosis.
Several factors such as diabetes, hypercholesterolemia, and smoking 22, 23) contributed to the short-and long-term cardiovascular events and restenosis after PCI. Although most baseline features in this study were not statistically different, certain factors such as male gender, smoking, the level of the total cholesterol, triglycerides, LDL-C and HDL-C, as well as LVEF were markedly different between the two groups due to the nonrandomized nature of choosing cases. These factors may result in the late losses of lumen area and MACEs. After removing the possible confounders, multivariate analysis further indicated that MB was also an independent risk factor of MACEs in addition to the known factors of age, high level of blood cholesterol, and LVEF.
Besides diabetes mellitus, significant tortuose lesions, resistance of antiplatelet drug, and the interventional technique were also crucial in increasing the risk of stent thrombosis. 24) Jiang reported that MB is a potential risk factor of stent thrombosis. 25, 26) In our study, there was one case with acute intrastent thrombosis that was diagnosed 4 h after PCI in the MB group. We considered that the periodical pressing of MB, which leads to distinct hemodynamic changes and critical endothelial injuries, may play an important role in stent thrombosis. No subacute or late thrombosis was found.
It was assumed that myocardial bridging would cause little myocardial ischemia owing to its specific physiological character that only influences the systolic coronary perfusion and seldom affects the diastolic blood perfusion. Nevertheless, recent studies had found that MB would lead to myocardial fibrosis, necrosis of contracting band, and increasing vascular density, which were closely associated with the occurrence of noncompaction of ventricular myocardium, 27) angina, acute myocardial infarction, 28) early repolarization, and malignant cardiac arrhythmias. 29, 30) MB periodically causes systolic luminal narrowing, which often extends to the diastolic period, especially when one is excited or doing exercises that lead to the reduction of coronary artery blood perfusion. Due to the specific hemodynamic states caused by MB, the rate of proximal coronary atherosclerosis was 86%. Previous studies reported that the shearing stress stimulates endothelial cells to release vascular active substances such as vasoconstrictors, inflammatory mediators and adhesive molecules, 31) promotes local inflammatory reaction, activates expression of atherogenic gene, and facilitates lipidic deposition. 32) After the stent implantation, these effects continuously inhibited endothelialization, stimulated proliferation of smooth muscle cells, and resulted in MACEs. 33) Our study also found that MB not only led to proximal atherosclerostic stenosis in LAD, but also resulted in occlusion with the ostium of proximate diagonal branches.
Clinical follow-up revealed that after stent implantation to the proximal stenosis of MB, the MACEs were mainly expressed as exerted angina of which the incidence was higher than angiographical restenosis. Most patients with recurrent angina had significant ECG changes, and nearly one-third of these patients were diagnosed with myocardial ischemia by myocardial radionuclide tomographic imaging using a using cardiac stress test. This indicated that besides restenosis, the presence of MB was also a main reason causing postprocedural angina. Limitations: There were several limitations in our study. First, this study was a prospective nonrandomized study and there could be a selected bias during the enrollment of patients. Second, intravascular ultrasound examination was not routinely performed for all cases to confirm the stent adherence, fracture, and intimal hyperplasia. Third, this study could not clearly elucidate the real prevalence of MB. Fourth, this study did not analyze the association of MB's length or depth with the luminal loss and the occurrence of MACEs.
Conclusions
Several problems regarding the efficacy and safety of stent implantation for atherosclerotic stenosis proximal to MB in LAD remain unclear. The initial results of this study may reveal some clinical significance. The existence of MB increases the incidence of proximal atherosclerostic lesions restenosis after stent implantation. For patients with MB in LAD, interventional therapy has a higher incidence of MACEs in the short-and long-term follow-ups. Moreover, the presence of MB is significantly associated with MACEs. Since this study is relatively small with single-centered experience, large-scale clinical studies are still needed.
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